Osmium absorption after osmium tetroxide skin and eye exposure.
acetone
chemical injury
electron microscopy
exposure
hereditary haemochromatosis
osmium tetroxide
Journal
Basic & clinical pharmacology & toxicology
ISSN: 1742-7843
Titre abrégé: Basic Clin Pharmacol Toxicol
Pays: England
ID NLM: 101208422
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
06
05
2020
revised:
28
05
2020
accepted:
02
06
2020
pubmed:
12
6
2020
medline:
24
8
2021
entrez:
12
6
2020
Statut:
ppublish
Résumé
Osmium tetroxide is a strong oxidizing agent used in electron microscopy. Eye exposure may cause severe burns, and after inhalation or ingestion damage to the respiratory or gastrointestinal tract occurs. Exposure to osmium and its compounds is extremely rare. We present a case of a 32-year-old female stained by 9 mL of 2% osmium tetroxide in acetone during an accident in the laboratory, with rare dermal and ocular findings. Due to lack of data in toxicological databases and the absence of antidote, the therapy was symptomatic. Osmium was detected in serum 19 hours later (0.22 μg/L) and in urine during the 15-hour collection (three samples-7.05, 1.65 and 8.45 μg/L). In blood serum on admission, after 1 and 2 days after exposure, the levels of iron (28.2, 39.8 and 50.5 μmol/L; reference range 5.8-34.5 μmol/L) and transferrin receptor/ferritine were elevated. To our knowledge, this is the first paper documenting a significant absorption from the skin and potentially from the eye conjunctiva, based on serum and urine analysis. The relationship between increased iron in blood and exposure has not been described yet, and the mechanism remains unknown. The patient is being followed up for the unknown long-term effects.
Substances chimiques
Osmium Tetroxide
P40W033BGM
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
429-433Subventions
Organisme : Charles University in Prague
ID : P25/1LF
Organisme : Charles University in Prague
ID : P29/1LF
Informations de copyright
© 2020 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). Published by John Wiley & Sons Ltd.
Références
Toxbase. Osmium. (2018). https://www.toxbase.org. Accessed April 1, 2020.
JoDrugs. Osmium tetroxide (2020). http://www.jodrugs.com/toxicologies/3241-osmium-tetroxide.aspx. Accessed April 1, 2020.
Micromedex. Osmium Tetroxide (2019). https://www.micromedexsolutions.com. Accessed April 1, 2020.
Mitchell N, Laurin C, Shepard N. The effect of osmium tetroxide and nitrogen mustard on normal articular cartilage. J Bone Joint Surg. 1973;55:814-821.
Makarovsky I, Markel G, Hoffman A, et al. Osmium tetroxide: a new kind of weapon. Isr Med Assoc J. 2007;9:750-752.
Ligon JJ, Abraham JL, Boyd AS. Traumatic osmium tetroxide inoculation. J Am Acad Dermatol. 2001;45:949-952.
Oustamanolakis P, Koutroubakis IE, Messaritakis I, Niniraki M, Kouroumalis EA. Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study. Ann Gastroenterol. 2011;24(2):108-114.
Honkanen E, Törnroth T, Pettersson E, Skrifvars B. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature. Clin Nephrol. 1987;27(2):87-93.
Baxter JP, Aw TC, Cockcroft A, Durrington P, Harrington JM. Hunter’s Diseases of Occupation. 10th edn. London, UK: Taylor & Francis CRC Press; 2010.
Barton JC, Edwards CQ. HFE Hemochromatosis. 2000 Apr 3 [Updated 2018 Dec 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington Seattle; 1993-2020.